InvestorsHub Logo
Followers 481
Posts 60467
Boards Moderated 18
Alias Born 09/20/2001

Re: nidan7500 post# 183453

Friday, 03/01/2019 5:30:15 PM

Friday, March 01, 2019 5:30:15 PM

Post# of 458800
IMGN did get some valuable knowledge out of that trial, it wasn't a total fail. The Yahoo article is misleading.

Missling's precision medicine approach is less costly and focuses on learning each step of the way.

Hopefully Anavex is experiencing volatility now but will have lower volatility once there are products on the market because it uses a precision medicine as opposed to the old pass/fail approach.



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News